Oncotarget is a term that includes all pathways, molecules, and cellular functions that are common in cancer and aging, atherosclerosis and neurodegeneration, lymphocytes and neurons, microbes and cancer cells.
New developments in the field of Oncology are happening at a remarkable pace. In order for Oncologists today to stay on top of these new developments it is essential to read academic journals and premier among the journals for oncologists is Oncotarget. The exciting news is that Oncotarget is now accepting papers on topics beyond oncology: such as Endocrinology, Neuroscience, Metabolism, Cardiology, Pharmacology, Cell Biology, and more.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/
Using the talent and information from professionals throughout the scientific community creates the best possible scenario for readers and ultimately patients alike, merging well-vetted facts with interesting information. Busy professionals can take advantage of the readability of this publication which allows the reader to make the best use of their time by eliminating the necessity of painstaking fact checking. The idea of gaining usable accurate and effective information from academic studies can be daunting. That’s what makes the way in which information is presented in Oncotarget that much more appealing to professionals. Highly specialized aspects of this journal can thus offer tremendous value to readers.
Oncotarget will keep oncologists and other related professionals informed of the latest developments regarding the most effective treatment options for patients with articles on cutting edge technology and techniques. With the information found in Oncotarget, professionals can feel confident in presenting new theories and future options to staff members. The papers or even entire issues published in Oncotarget online weekly can be printed for special demand. This professional journal helps all researchers, under the leadership of the most prominent scientists contribute to the progress of science. Oncotarget, which is published by Impact Journals
Oncotarget states that their mission is to make available scientific results rapidly and widely, and through insightful review, maximize the impact of research allowing exceptional discoveries to rapidly be shared. They eliminate the border that exists between specialties and link different biomedical science fields. All this allows them to effectively advance applications of basic and clinical science to fight disease. The ultimate goal of Oncotarget is life without disease.